EXPLORE THE SCIENCE
Guanfacine extended release (GXR) may effectively improve cognitive impairments and brain activity in long-COVID patients. Highlights: Patient Presentation: A 32-year-old woman experienced cognitive impairments such as difficulty in word recall, reading, and w…
Read article
A study found that adults recovering from their first COVID-19 infection more than 1-year ago have higher levels of fatigue and other chronic neuropsychiatric symptoms, influenced by vaccination status and socioeconomic factors. Highlights: Adults who had thei…
Read article
TLDR: Objective olfactory dysfunction 1-3 months after COVID-19 predicts post-COVID condition (PCC) and reduced quality of life after one year, while subjective symptoms do not. Highlights: Individuals with objectively measured olfactory dysfunction shortly af…
Read article
Long COVID syndrome (LCS) is a complex, chronic condition that can arise after COVID-19 infection. Key facts about LCS: Affects an estimated 10-30% of COVID survivors Causes debilitating symptoms lasting months to years after initial infection Impacts nearly e…
Read article
A new retrospective study analyzing data from over 33,000 COVID-19 patients points to omega-3 fatty acids as a potential preventive strategy against the psychiatric aftereffects of the illness. Key findings: Patients taking omega-3 supplements before COVID-19…
Read article